DYAZIDE - 0007-3650-30 - (hydrochlorothiazide and triamterene)

Alphabetical Index


Drug Information of DYAZIDE

Product NDC: 0007-3650
Proprietary Name: DYAZIDE
Non Proprietary Name: hydrochlorothiazide and triamterene
Active Ingredient(s): 25; 37.5    mg/1; mg/1 & nbsp;   hydrochlorothiazide and triamterene
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of DYAZIDE

Product NDC: 0007-3650
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA016042
Marketing Category: NDA
Start Marketing Date: 19940330

Package Information of DYAZIDE

Package NDC: 0007-3650-30
Package Description: 1000 CAPSULE in 1 BOTTLE (0007-3650-30)

NDC Information of DYAZIDE

NDC Code 0007-3650-30
Proprietary Name DYAZIDE
Package Description 1000 CAPSULE in 1 BOTTLE (0007-3650-30)
Product NDC 0007-3650
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name hydrochlorothiazide and triamterene
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 19940330
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name HYDROCHLOROTHIAZIDE; TRIAMTERENE
Strength Number 25; 37.5
Strength Unit mg/1; mg/1
Pharmaceutical Classes Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC]

Complete Information of DYAZIDE


General Information